Background/Aims: Regional citrate anticoagulation (RCA) during hemodialysis (HD) has several advantages over heparin anticoagulation, but calcium (Ca) derangements are a major concern necessitating repeated monitoring of systemic ionized Ca (Ca2+). We developed a mathematical model of Ca and citrate (Ci) kinetics during RCA. Methods: Using patient- and treatment-related parameters, including pre-HD serum Ca and protein concentrations, hematocrit, blood and dialysate flow rates, dialysate composition and access recirculation, the model computes all relevant aspects of RCA based on physicochemical, biochemical and physiological principles such as chemical Ca and Ci equilibria, transmembrane solute fluxes and Ci metabolic rate. The model was validated in 17 treatments using arterial Ci infusion, Citrasate® dialysate, and no postdialyzer Ca substitution. Results: Measured and predicted systemic Ca2+ before HD was 1.08 ± 0.06 and 1.05 ± 0.05 mmol/l, respectively (difference –0.03 ± 0.046, 95% confidence interval, CI, –0.055 to –0.007), and at 15 min into the treatment 1.01 ± 0.05 and 1.02 ± 0.05 mmol/l, respectively (difference 0.012 ± 0.054, 95% CI –0.015 to 0.04). At 15 min, the measured and predicted predialyzer Ca2+ was 0.33 ± 0.06 and 0.39 ± 0.05 mmol/l, respectively (difference 0.06 ± 0.03; 95% CI 0.044–0.077), and the measured and predicted postdialyzer Ca2+ was 0.7 ± 0.05 and 0.61 ± 0.05 mmol/l, respectively (difference –0.09 ± 0.04; 95% CI –0.11 to –0.07). Bland-Altman analysis showed no systematic bias in these predictions. Conclusion: This novel model of RCA shows excellent accuracy in predicting systemic, pre- and postdialyzer Ca2+ concentrations and may prove valuable in both research and clinical applications of RCA.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.